Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

No longer available × Neoplasm Metastasis × Tumor-Agnostic × Clear all

Status

Completed 280 Recruiting 140 Unknown 83 Terminated 78 Active not recruiting 61 Not yet recruiting 21 Withdrawn 20 Suspended 4 No longer available 2 Enrolling by invitation 1 Available 1 Approved for marketing 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Tumor-Agnostic 2 Gastrointestinal 1

Conditions

Neoplasms 6 Neoplasm Metastasis 2

Interventions

selitrectinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03206931 2021-09-16

Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene Fusion

Bayer

No longer available

Neoplasm Metastasis

NCT02473653 2017-08-11

Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer

University of Pennsylvania

No longer available

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡